MESSAGE FROM THE PRESIDENT
Welcome to the 768th meeting of the New England Ophthalmological Society. Again. we have a captivating program for you that will enhance your acumen and practice. Enjoy.
I would like to invite all NEOS members to review the Ophthalmic Services Committee minutes. This is a permanent committee of the Board. It is the only such committee, as far as we know, in the US of its kind. It always great information as regards insurance and practice updates.
Another NEOS advantage is the Hal Freeman Video Library. This has been made much more viewer friendly as of late. It is a fabulous resource that all NEOS members should take advantage of.
We continue to have early morning Grand Rounds presented by the various ophthalmic residency programs throughout New England. The cases presented are thought provoking and the panel of attendings does a great job in developing the differential diagnostic lists.
Enjoy your stay in Boston. Again, thank you for your attendance.
John J. Dagianis, MD
GUEST OF HONOR AND JOAN W. MILLER, MD, LECTURER
PETER K. KAISER, MD
Peter K. Kaiser, MD graduated magna cum laude with Highest Honors from Harvard College and magna cum laude from Harvard Medical School. He completed an internal medicine internship at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute before joining the vitreoretinal department of the Cole Eye Institute at the Cleveland Clinic Foundation, Cleveland, Ohio where he is the Chaney Family Endowed Professor of Ophthalmology Research at the Cleveland Clinic Lerner College of Medicine.
As a National Eye Institute and National Institute of Health RO1-funded principle investigator, Dr. Kaiser leads a team involved in the evaluation of vascular biology in age-related macular degeneration (AMD) and diabetic retinopathy (DR). In addition, Dr Kaiser is actively involved in clinical research having served as Study Chairman for numerous major, multi-center, international clinical trials, and principal investigator in over 60 trials evaluating new treatments for AMD, DR, and other retinal disorders. He is the founder and director of the Digital Optical Coherence Tomography Reading Center (DOCTR), which is the OCT reading center for over 700 international sites and 45 multi-center, clinical trials. Dr. Kaiser has been honored to receive the Lew R. Wasserman Award from the Research to Prevent Blindness for his research. Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. He is a major contributor to the medical literature having authored 7 textbooks, 25 book chapters, and more than 250 peer-reviewed manuscripts. He is Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, and serves on the editorial boards of American Journal of Ophthalmology, Retina, Retina Today, and Ocular Surgery News. Dr. Kaiser has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with Achievement and Senior Achievement Awards, and has been listed as one of the “Best Doctors in America” since 2002. He is the team ophthalmologist for the Cleveland Cavaliers (National Basketball Association).
JOAN W. MILLER, MD, LECTURE
Joan W. Miller, MD, is the David Glendenning Cogan Professor of Ophthalmology and Chair of the Department of Ophthalmology at Harvard Medical School (HMS), and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital. Dr. Miller earned her medical degree and received her ophthalmology residency training from Harvard Medical School, and then completed fellowships in ophthalmology research and vitreoretinal surgery at Mass. Eye and Ear. In 2003, Dr. Miller became the first female physician to achieve the rank of Professor of Ophthalmology at Harvard Medical School, and the first woman to serve as chair of the Department of Ophthalmology. She is also the first woman appointed as Chief of Ophthalmology at both Mass. Eye and Ear and Massachusetts General Hospital.
An internationally recognized expert on retinal disorders, Dr. Miller is credited with developing verteporfin photodynamic therapy (PDT), the first pharmacologic treatment for retinal disease; co-discovering the role of vascular endothelial growth factor (VEGF) in neovascular eye disease; and demonstrating the therapeutic potential of VEGF inhibitors in neovascular eye disease. Her current studies focus on the genetics of age-related macular degeneration (AMD), strategies for early intervention in AMD, and neuroprotective therapies for retinal disease.
Dr. Miller has authored more than 200 original research articles and nearly 80 book chapters, review articles, or editorials. Dr. Miller is on the editorial board for the journals Ophthalmology and Ophthalmology Retina and an editor of several textbooks, including the 3rd edition of Albert and Jakobiec’s Principles and Practice of Ophthalmology (Saunders). Dr. Miller is a member of the National Academy of Medicine, the Academia Ophthalmologica lnternationalis, and the Dowling Society, as well as a Gold Fellow of Association for Research in Vision and Ophthalmology (ARVO). Among her numerous honors, Dr. Miller delivered the 2012 Edward Jackson Lecture for the American Academy of Ophthalmology, and was a co-recipient of the 2014 António Champalimaud Vision Award, the highest distinction in ophthalmology and visual science. In 2015, Dr. Miller became the first woman to receive the Mildred Weisenfeld Award for Excellence in Ophthalmology from the Association for Research in Vision and Ophthalmology (ARVO).
Since 2006, Dr. Miller has served in several leadership capacities for the New England Ophthalmological Society, including: Program Committee member, Program Committee Co-Chair (2016), Admissions Committee member, Vice President, and President (2013-2014).
GUEST OF HONOR
RONALD KRUEGER, MD
Dr. Ronald R. Krueger, Medical Director of Refractive Surgery at the Cleveland Clinic Cole Eye Institute in Ohio, is a renowned ophthalmologic surgeon with more than 30 years of experience in the field of refractive surgery, specifically in excimer and femtosecond laser research and wave front optics.
In 1982, Dr. Krueger graduated Summa Cum Laude from Rutgers University with a BSEE in Electrical Engineering , followed by an MSE in Bioengineering from the University of Washington in the following year. After receiving his medical training at the UMDNJ -New Jersey Medical School in 1987, he completed a Residency in Ophthalmology at Columbia Presbyterian Medical Center in New York City in 1991, followed by both a Cornea Fellowship at the Dean McGee Eye Institute at the University of Oklahoma and a Refractive Surgery Fellowship at the Doheny Eye Institute of the University of Southern California in 1993.
Professionally, Dr. Krueger has performed over 20,000 refractive surgery procedures and has published more than 150 peer-reviewed manuscripts, as well as numerous abstracts, book chapters and trade journal articles. He is credited with documenting the first physical description of the effects of the excimer lasers on corneal tissue in 1985, and coauthoring the first book on “Wavefront Customized Corneal Ablation” in 2001. He also pioneered the development of femtosecond laser treatment of the crystalline lens and cataracts, leading to the co-founding of LensAR, Inc in 2004, and publication of the first textbook on the subject in 2013, “Refractive Laser Assisted Cataract Surgery (ReLACS)”.
Dr. Krueger teaches as a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He recently served as the President of the International Society of Refractive Surgery in partnership with the American Academy of Ophthalmology (ISRS/AAO) for years of 2014 & 2015. In addition, Dr. Krueger serves as the Associate Editor of the Journal of Refractive Surgery over the past 20 years, and has lectured on refractive surgery in more than 40 countries.
Dr. Krueger has received numerous awards, including the National Leadership Award, Castle Connolly America’s Top Doctors award in 2005 and 2010, the 2007 Kritzinger Memorial Award of the ISRS/AAO and the 2008 Lans Distinguished Award of the ISRS/AAO. In 2013, his thesis, “Ultrashort-Pulse Lasers Treating the Crystalline Lens: Will They Cause Vision Threatening Cataract?” was accepted for membership in the American Ophthalmological Society (AOS), the oldest and most prestigious in U.S. Ophthalmology. In 2018, he will receive the Jose I. Barraquer Award and Lecture at the AAO meeting, which is the most prestigious honor in Refractive Surgery.